Company logo

BCYC - Bicycle Therapeutics plc

NASDAQ -> Healthcare -> Biotechnology
Cambridge, United Kingdom
Type: Equity

BCYC price evolution
BCYC
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $526.42 $572.09 $340.43 $293.82
Short term investments
Net receivables $24.04 $17.28 $57.97 $76.51
Inventory
Total current assets $561.87 $603.04 $408.43 $381.25
Long term investments
Property, plant & equipment $27.68 $30.2 $33.59 $36.98
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $595.34 $638.68 $454.17 $428.8
Current liabilities
Accounts payable $13.05 $8.49 $5.25 $2.81
Deferred revenue
Short long term debt $4.66 $4.68 $4.66
Total current liabilities $69.54 $69.74 $72.27 $53
Long term debt $30.7 $30.6 $30.51 $30.42
Total noncurrent liabilities
Total debt
Total liabilities $224.41 $222.66 $234.07 $185.64
Shareholders' equity
Retained earnings -$511.76 -$462.66 -$412.76 -$370.16
Other shareholder equity -$1.3 $2.88 -$0.88 $0.07
Total shareholder equity $370.93 $416.02 $220.1 $243.16
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $526.42 $339.15 $438.68 $135.99
Short term investments
Net receivables $24.04 $21.21 $11.91 $14.63
Inventory
Total current assets $561.87 $369.38 $458.56 $155.72
Long term investments
Property, plant & equipment $27.68 $32.77 $17.79 $3.61
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $595.34 $410.61 $479.79 $161.15
Current liabilities
Accounts payable $13.05 $6.47 $2.72 $1.36
Deferred revenue
Short long term debt $3.12 $2.38
Total current liabilities $69.54 $53.34 $36.24 $23.13
Long term debt $30.7 $30.32 $29.87 $14.51
Total noncurrent liabilities
Total debt
Total liabilities $224.41 $139.83 $133.54 $65.69
Shareholders' equity
Retained earnings -$511.76 -$331.1 -$218.38 -$151.56
Other shareholder equity -$1.3 $0.39 -$3.39 -$3.19
Total shareholder equity $370.93 $270.78 $346.25 $95.46
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $5.33 $5.35 $11.4 $4.9
Cost of revenue $38.17 $37.14 $4.6
Gross Profit -$32.82 -$25.75 $0.3
Operating activities
Research & development $45.13 $45.74 $27.62
Selling, general & administrative $17.98 $17.36 $14.49
Total operating expenses $59.75 $56.15 $54.51 $46.7
Operating income -$50.8 -$43.11 -$41.8
Income from continuing operations
EBIT
Income tax expense $0.32 $2.27 -$0.52 -$0.62
Interest expense $5.64 -$0.81 -$0.82 -$0.81
Net income
Net income -$49.1 -$49.9 -$42.6 -$39.06
Income (for common shares) -$49.9 -$42.6 -$39.06
(in millions $) 31 Dec 2023 31 Jan 2023 31 Jan 2022 31 Jan 2021
Revenue
Total revenue $26.98
Cost of revenue $156.5
Gross Profit -$129.52
Operating activities
Research & development $180.96
Selling, general & administrative $60.43
Total operating expenses $216.92
Operating income -$189.95
Income from continuing operations
EBIT
Income tax expense $1.46
Interest expense -$3.26
Net income
Net income -$180.66
Income (for common shares) -$180.66
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$49.1 -$49.9 -$42.6 -$39.06
Operating activities
Depreciation $1.65 $1.69 $1.64 $1.56
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$47.29 -$1.02 $34.1 -$46.41
Investing activities
Capital expenditures -$0.05 -$0.5 -$0.28 -$2.1
Investments
Total cash flows from investing -$0.05 -$0.5 -$0.28 -$2.1
Financing activities
Dividends paid
Sale and purchase of stock $234.63 $12.29 $2.72
Net borrowings
Total cash flows from financing $0.39 $234.63 $12.29 $2.72
Effect of exchange rate
Change in cash and equivalents -$45.66 $232.2 $46.62 -$45.34
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$180.66 -$112.72 -$66.82 -$51.01
Operating activities
Depreciation $6.55 $3.69 $1.41 $1.28
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$60.63 -$86.11 -$14.79 -$17.79
Investing activities
Capital expenditures -$18.99 -$2.03 -$1.2
Investments
Total cash flows from investing -$2.93 -$18.99 -$2.03 -$1.2
Financing activities
Dividends paid
Sale and purchase of stock $250.03 $6.69 $305.73 $48.42
Net borrowings $15 $15
Total cash flows from financing $250.03 $6.69 $320.73 $62.84
Effect of exchange rate -$1.21 $0.02
Change in cash and equivalents $187.82 -$99.53 $302.69 $43.87
Fundamentals
Market cap $941.83M
Enterprise value N/A
Shares outstanding 37.82M
Revenue $26.98M
EBITDA N/A
EBIT N/A
Net Income -$180.66M
Revenue Q/Q 67.64%
Revenue Y/Y N/A
P/E ratio -5.21
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 34.91
P/B ratio 2.53
Book/Share 9.84
Cash/Share 13.92
EPS -$4.78
ROA -34.14%
ROE -57.80%
Debt/Equity 0.60
Net debt/EBITDA N/A
Current ratio 8.08
Quick ratio N/A